PMDA — authorised 20 June 2022
- Marketing authorisation holder: TAIHO PHARMACEUTICAL CO., LTD
- Status: approved
PMDA authorised Jeselhy on 20 June 2022
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 20 June 2022; PMDA has authorised it.
TAIHO PHARMACEUTICAL CO., LTD holds the Japanese marketing authorisation.